PLASMA CELL MYELOMA
Clinical trials for PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Veto cells may help stem cell transplants work better and safer
Disease control OngoingThis early-phase trial tests whether adding special 'veto' cells to a stem cell transplant can help donor cells grow in the patient's body without causing severe graft-versus-host disease. It includes 16 people aged 12-75 with various blood cancers or bone marrow failure. The vet…
Matched conditions: PLASMA CELL MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 01, 2026 15:27 UTC
-
New transplant combo aims to tame Graft-Versus-Host disease
Disease control OngoingThis study tests a stem cell transplant method for people with blood cancers like leukemia or lymphoma. The approach combines chemotherapy and radiation before transplant with a drug called cyclophosphamide after transplant to lower the risk of graft-versus-host disease, where do…
Matched conditions: PLASMA CELL MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 01, 2026 15:25 UTC
-
New cocktail of drugs shows promise against bone marrow cancer
Disease control OngoingThis study tests a new drug, iberdomide, combined with three other drugs (daratumumab, bortezomib, and dexamethasone) in people newly diagnosed with multiple myeloma, a type of blood cancer. The goal is to find the best dose of iberdomide and see how well the combination works at…
Matched conditions: PLASMA CELL MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
New drug cocktail aims to wipe out hidden myeloma cells after transplant
Disease control OngoingThis study tests whether a combination of belantamab mafodotin (a targeted chemotherapy) and lenalidomide can eliminate leftover cancer cells in multiple myeloma patients who still have signs of disease after a stem cell transplant. The goal is to achieve a state called minimal r…
Matched conditions: PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Apr 29, 2026 15:14 UTC
-
Major trial tests best combo for myeloma control
Disease control OngoingThis study compares two drug combinations (VRd and CRd) in over 1,000 people with newly diagnosed multiple myeloma to see which works better at controlling the cancer. After initial treatment, patients receive maintenance therapy with lenalidomide to keep the disease in check. Th…
Matched conditions: PLASMA CELL MYELOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC